ID
11999
Description
Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01984606
Link
https://clinicaltrials.gov/show/NCT01984606
Keywords
Versions (1)
- 8/31/15 8/31/15 -
Copyright Holder
ODM derived from: https://clinicaltrials.gov/show/NCT01984606
Uploaded on
August 31, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes Mellitus, Type 2 NCT01984606
Eligibility Diabetes Mellitus, Type 2 NCT01984606
- StudyEvent: Eligibility
Description
Exclusion Criteria
Description
glucose; mmol/l; dose
Data type
boolean
Alias
- UMLS CUI [1]
- C0020456
Description
treatment; other; drug
Data type
boolean
Alias
- UMLS CUI [1]
- C0935929
Description
treatment; metformin; other; drug
Data type
boolean
Alias
- UMLS CUI [1]
- C0935929
Description
acute coronary syndrome; informed consent; unstable angina; angina pectoris; stroke; stemi; non
Data type
boolean
Alias
- UMLS CUI [1]
- C0948089
Description
liver disease; indication
Data type
boolean
Alias
- UMLS CUI [1]
- C0023895
Description
impairment; moderate; severe; renal
Data type
boolean
Alias
- UMLS CUI [1]
- C1565489
Description
surgery
Data type
boolean
Alias
- UMLS CUI [1]
- C1456587
Description
informed consent; treatment; obesity; drugs
Data type
boolean
Alias
- UMLS CUI [1]
- C0376607
Description
diabetes mellitus; informed consent; type 2 diabetes; treatment; steroids; disorder; other; systemic; current; time
Data type
boolean
Alias
- UMLS CUI [1]
- C2825233
- UMLS CUI [2]
- C0014130
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT01984606
- StudyEvent: Eligibility
C0014130 (UMLS CUI [2])